ITRM
Iterum Therapeutics plc Ordinary Share
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
ITRM Stock Analysis: Buy, Sell, or Hold?
$0.03
-0.04 (-57.39%)
▼
5d:
-82.12%
30d:
-89.38%
90d:
-89.62%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Mar 12, 2026
Updated Mar 31, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (64%)
Quality Score
43/100
Position
FAIR
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$9.00
+29900.0% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.03 / $0.18
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ITRM is down 82.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When ITRM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ITRM is currently trading at $0.03, which is considered fair based on recent price action.
Technical Outlook: Technically, ITRM is in a strong downtrend. Immediate support is located at $0.03, while resistance sits at $0.18. Short-term momentum is weak, with the stock down 57.4% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.00 (+29900.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ITRM is in a strong downtrend. Immediate support is located at $0.03, while resistance sits at $0.18. Short-term momentum is weak, with the stock down 57.4% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.00 (+29900.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
43/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Trading Range & Key Levels
Support Level
$0.03
Resistance Level
$0.18
Current Trend
Strong Downtrend
Technical data as of
Mar 31, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-57.4%)
- BULLISH: Trading 29900.0% below Wall St target ($9.00)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.10
Wall Street Target
$9.00
(+29900.0%)
Revenue Growth (YoY)
-100.0%
Share ITRM Analysis
Share this live ITRM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ITRM)
Bearish
5 Retail Mentions
Reddit / WSB Comments
1
Bearish
Retail Stream Volume
4 msgs
24h retail stream
Last Tracked
Apr 1, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate bullish sentiment towards $ITRM with traders expressing confidence in its potential growth and faster Irish High Court liquidation process. No recent news articles were available.
Key Retail Themes:
Bullish sentiment towards $ITRM
Accelerated liquidation process in Ireland
Aggregated from r/wallstreetbets, r/stocks & retail trader streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 22, 2026 6:04 AM ET
Data refreshes hourly during market hours. Next update: 7:04 AM
Data refreshes hourly during market hours. Next update: 7:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ITRM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$300 | 63 BUY |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$469 | 49 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$595 | 41 HOLD |
|
KURA
Kura Oncology Inc |
STRONG BUY
16 analysts |
$32 | 76 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$315 | 38 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ITRM Research Pages
ITRM Technical Chart
ITRM Price Prediction
ITRM Intrinsic Value DCF
ITRM Earnings Date
ITRM Investment Advisor
ITRM Fair Price Analyzer
ITRM Target Price Playground
ITRM 5-Day Options Simulator
ITRM LEAP Simulator
ITRM Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
ITRM Competitors
Part B: Tradestie Flagship Market Scanners